BPC-157 — 500mcg | Research Use Only (RUO)

Description

A synthetic pentadecapeptide currently investigated in controlled laboratory environments for its interactions with gastrointestinal protective mechanisms, cellular signaling pathways, angiogenic processes, and experimental tissue-response models.

For laboratory research use only. Not for human or animal consumption.

OVERVIEW

BPC-157 is a synthetic 15-amino-acid peptide with the sequence GEPPPGKPADDAGLV. It is derived from research involving peptide fractions associated with human gastric proteins and has been studied extensively in preclinical laboratory models.

Experimental research has examined BPC-157 in relation to gastrointestinal mucosal protection, nitric-oxide signaling, vascular and endothelial responses, angiogenic pathways, cellular migration, and tissue-response mechanisms.

Although BPC-157 has been investigated across a variety of preclinical models, human research remains limited and no approved therapeutic use has been established.

Supplied in capsule form for analytical, formulation, and controlled experimental research applications.

PRODUCT SPECIFICATIONS

Compound: BPC-157
Quantity: 500 mcg per capsule
Capsule Count: 30 capsules
Form: Capsule
Compound Class: Synthetic pentadecapeptide
Amino Acid Sequence: GEPPPGKPADDAGLV
Molecular Weight: Approximately 1419 Da
Purity: See batch-specific Certificate of Analysis
Storage: Store under cool, dry conditions protected from excessive heat, moisture, and direct light. Follow batch-specific handling instructions where provided.

RESEARCH APPLICATIONS

• Gastric and gastrointestinal signaling research
• Gastrointestinal mucosal-response models
• Nitric-oxide signaling pathway studies
• Endothelial and vascular-response research
• Angiogenesis pathway investigation
• Cellular migration and signaling studies
• Experimental tissue-response models
• Peptide stability and formulation research

RESEARCH BACKGROUND

BPC-157 has been investigated primarily in preclinical models examining gastrointestinal, vascular, musculoskeletal, and cellular-response mechanisms.

Published laboratory research has explored potential interactions involving nitric-oxide pathways, endothelial signaling, angiogenic mechanisms, growth-factor-related signaling, and cellular responses associated with experimental tissue injury.

Its 15-amino-acid structure and reported stability under certain experimental gastrointestinal conditions have also made BPC-157 a subject of interest in peptide stability, formulation, and gastrointestinal research.

Current scientific evidence remains predominantly preclinical. Human data are limited, and BPC-157 has not been established as an approved therapeutic agent.

RESEARCH USE ONLY

This product is intended strictly for laboratory research purposes. Not for human consumption. Not for veterinary use. Not for therapeutic or diagnostic applications. Not intended to treat, cure, or prevent any condition.

The capsule format is provided solely as a research formulation and should not be interpreted as an approved oral pharmaceutical preparation.

Use is limited to qualified professionals in controlled laboratory environments.

Certificate of Analysis available upon request.